Correlation Between Avadel Pharmaceuticals and NeuroSense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Avadel Pharmaceuticals and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and NeuroSense Therapeutics.

Diversification Opportunities for Avadel Pharmaceuticals and NeuroSense Therapeutics

-0.44

Correlation Coefficient

Avadel Pharmaceuticals  NeuroSense Therapeutics

Very good diversification

The 3 months correlation between Avadel and NeuroSense is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and NeuroSense Therapeutics go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and NeuroSense Therapeutics

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avadel Pharmaceuticals PLC is 10.95 times less risky than NeuroSense Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  17.00  in NeuroSense Therapeutics Ltd on September 16, 2024 and sell it today you would earn a total of  8.00  from holding NeuroSense Therapeutics Ltd or generate 47.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	66.67%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  NeuroSense Therapeutics Ltd

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

NeuroSense Therapeutics

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Avadel Pharmaceuticals and NeuroSense Therapeutics

The main advantage of trading using opposite Avadel Pharmaceuticals and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.

The idea behind Avadel Pharmaceuticals PLC and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.